<< Previous Page Displaying 33 through 40 of 41 Next Page >>
|
| Google Founder Reveals Risk of Parkinson's in his genes |
| Tuesday, October 7, 2008 |
| Google cofounder Sergey Brin has finally started a personal blog, and
he went from describing his title choice to revealing some significant
health news: he is at potentially high risk for contracting Parkinson's
disease.
|
| |
| Omeros Corp. and Parkinson's Institute collaborate on Motion Disorder Target |
| Wednesday, September 17, 2008 |
| Seattle, Washington and Sunnyvale, California – September 17, 2008 – Omeros Corporation and The Parkinson’s Institute and Clinical Center today announced that they have entered into a collaboration to evaluate a novel target, proprietary to Omeros, for the treatment of movement disorders.
|
| |
| Parkinson's Institute Researcher to present at NPF 6th Annual Young-Onset Parkinson Network Conference |
| Thursday, June 26, 2008 |
Dr. Sam Goldman of the Parkinson's Institute and Clinical Center presents Epidemiology Meets the Internet: Building a New Approach for PD Clinical Research
DATE: Saturday, August 9 at the Omni Hotel at CNN Center in Atlanta, GA.
|
| |
| Genetics firm to build online health database |
| Thursday, May 15, 2008 |
| The private Mountain View company, which offers customers a personal scan of their DNA for $999,
formed its first research alliance with the Parkinson's Institute and
Clinical Center in Sunnyvale.
|
| |
| Parkinson's Institute known far and wide, except here. |
| Friday, January 25, 2008 |
| A longtime resident of the Bay Area with Parkinson's disease returned to her native Korea to consult a specialist. On discovering where she lives, the doctor asks why she's traveled across the ocean when she's only three miles away from one of the best and largest Parkinson's centers in the world. To read the full article click here. |
| |
| Michael J. Fox Foundation commits up to $3.8 Million to develop gene silencing neuroprotective treatment for Parkinson's Disease |
| Thursday, January 3, 2008 |
| The Michael J. Fox Foundation has committed up to $3.8 million for the
development of a gene silencing therapeutic to treat Parkinson’s disease by
reducing expression of the protein alpha-synuclein. A team of researchers led by Matt Farrer, PhD, of Mayo Clinic Jacksonville (Florida) with collaborators at Alnylam Pharmaceuticals and The Parkinson’s |
| |
| The Annals of Neurology publishes Nicotine Study |
| Wednesday, October 24, 2007 |
| The Parkinson’s Institute and Clinical Center
today announced research showing that intermittent nicotine treatment reduces
medication-induced dyskinesias by as much as 50 percent in models of Parkinson’s
disease. To read the Full Article click here. |
| |
| Parkinson's Disease Foundation Educational Symposium |
| Thursday, October 11, 2007 |
| Dr. Tanner speaks to the importance of epidemiology research to reveal the Patterns of PD in various populations and to
potentially discover clues to the cause of Parkinson's Disease. Click here to
view Dr. Tanner's presentation. The Symposium covered many topics
over the space of two days. You can view any and all sessions from the Symposium
by |
| |
<< Previous Page Next Page >>
|
